Recent research has illuminated the expanding potential of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, which were initially approved for diabetes management...
By 193cc Agency CouncilSeptember 5, 2024Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for weight loss and diabetes management, are now being investigated for their potential...
By 193cc Agency CouncilJuly 16, 2024A recent study published in JAMA Ophthalmology suggests that using Ozempic or Wegovy may elevate the risk of a rare form of blindness...
By 193cc Agency CouncilJuly 4, 2024A recent study published in the journal JAMA Network indicates that medications such as Ozempic and Wegovy, popular for weight loss, may lead...
By 193cc Agency CouncilJune 26, 2024In a comprehensive report analyzing trends in cosmetic surgery, 2023 saw a significant uptick in procedures such as fillers, Botox injections, facelifts, and...
By 193cc Agency CouncilJune 26, 2024Ozempic manufacturer Novo Nordisk announced on Tuesday that its popular weight loss drug Wegovy has been approved for sale in China. This approval...
By 193cc Agency CouncilJune 26, 2024A comprehensive study recently conducted has shed new light on the potential correlation between GLP-1 medications like Ozempic and Wegovy and the risk...
By 193cc Agency CouncilApril 10, 2024